13th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine

Friday, November 15, 2024, 2:00 PM - Saturday, November 16, 2024, 6:00 PM PST, Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA


This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on precision medicine, gynecological malignancies, hematologic malignancies, prostate, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.

1. Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trial data and apply relevant findings into the management of cancer patients
2. Develop personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options
3. Integrate appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes
4. Utilize AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
5. Review the principles, techniques, and applications of precision medicine, including genomic and molecular profiling, biomarker discovery, targeted therapies, and personalized care, in order to appreciate the potential benefits, limitations, and ethical considerations of this emerging approach to healthcare.

---

In- person Fee
Physicians (In-Person) : Free
All Other Healthcare Providers (In- Person): Free
Residents/Fellows/Medical Students (In- Person): Free
CSHS Advanced Practice Providers/Researchers/Administration (In- Person): Free
Industry (In- Person): $225.00

Refund Policy
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.  

---

Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

DESIGNATION OF CREDIT:
AMA for Physicians: Cedars-Sinai designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA Attendance for Non-Physicians: Attendance credit will be provided to other health care professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

AMA PRA Category 1 Credit(s)™ (MD, DO) (9.50 hours), Non-Physician AMA Attendance (9.50 hours)

The registration form for this activity is currently unavailable.

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.